Connection
Cheryl Ackert-Bicknell to Thiazolidinediones
This is a "connection" page, showing publications Cheryl Ackert-Bicknell has written about Thiazolidinediones.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.366 |
|
|
|
-
Ackert-Bicknell CL, Shockley KR, Horton LG, Lecka-Czernik B, Churchill GA, Rosen CJ. Strain-specific effects of rosiglitazone on bone mass, body composition, and serum insulin-like growth factor-I. Endocrinology. 2009 Mar; 150(3):1330-40.
Score: 0.300
-
Lecka-Czernik B, Ackert-Bicknell C, Adamo ML, Marmolejos V, Churchill GA, Shockley KR, Reid IR, Grey A, Rosen CJ. Activation of peroxisome proliferator-activated receptor gamma (PPARgamma) by rosiglitazone suppresses components of the insulin-like growth factor regulatory system in vitro and in vivo. Endocrinology. 2007 Feb; 148(2):903-11.
Score: 0.066